Skip to main content

Table 1 Depression in RA patients analyzed by demographic characteristics

From: The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan

Characteristics

Overall, N (%)

No depression, N (%)

Mild depression, N (%)

Moderate to severe depression, N (%)

P-value

Patients

500

324 (65)

118 (24)

58 (11)

 

Age (mean ± SD)

54.28 ± 10.02

56.04 ± 9.91

51.57 ± 10.02

49.93 ± 9.59

<0.001

  ≤ 50 years

178 (36)

94 (29)

53 (45)

31 (54)

 

 51–60 years

196 (39)

130 (40)

45 (38)

21 (36)

 

  > 60 years

126 (25)

100 (31)

20 (17)

6 (10)

 

Gender

0.036

 Male

163 (33)

118 (37)

28 (24)

17 (29)

 

 Female

337 (67)

206 (64)

90 (76)

41 (71)

 

Marital status

0.004

 Single

97 (19)

49 (15)

34 (29)

14 (24)

 

 Married

403 (81)

275 (85)

84 (71)

44 (76)

 

Highest Education

0.109

 High school or less

180 (36)

107 (33)

47 (40)

26 (44)

 

 College

120 (24)

74 (23)

30 (25)

16 (28)

 

 Bachelor’s degree or higher

200 (40)

143 (44)

41 (35)

16 (28)

 

Occupation

0.141

 Full-time

164 (33)

112 (34)

36 (30)

16 (28)

 

 Part-time

78 (16)

43 (13)

26 (22)

9 (15)

 

 Self-employed

37 (7)

28 (9)

6 (5)

3 (5)

 

 Housewife

141 (28)

89 (27)

33 (28)

19 (33)

 

 Retired

20 (4)

18 (6)

1 (1)

1 (2)

 

 Unemployed

57 (11)

32 (10)

16 (14)

9 (15)

 

 Other

3 (1)

2 (1)

0 (0)

1 (2)

 

Region

 Hokkaido

26 (5)

15 (5)

4 (3)

7 (12)

0.038

 Tohoku

23 (5)

17 (5)

4 (3)

2 (3)

0.645

 Kanto

230 (46)

147 (45)

53 (46)

30 (52)

0.646

 Chubu

63 (13)

45 (14)

10 (8)

8 (14)

0.303

 Kansai

95 (19)

58 (18)

30 (25)

7 (12)

0.073

 Chugoku

21 (4)

14 (4)

7 (6)

0 (0)

0.180

 Shikoku

11 (2)

6 (2)

2 (2)

3 (5)

0.259

 Kyushu

31 (6)

22 (7)

8 (7)

1 (2)

0.323

Annual individual income

  < 3.7 M Yen

286 (57)

173 (53)

73 (62)

40 (69)

0.272

 3.7–7.7 M Yen

105 (21)

74 (23)

22 (19)

9 (15)

 

  > 7.7 M Yen

45 (9)

34 (11)

7 (6)

4 (7)

 

I don’t know

64 (13)

43 (13)

16 (13)

5 (9)

 

Time since diagnosis (mean ± SD)

10.67 ± 8.63

10.45 ± 8.99

11.07 ± 8.07

11.12 ± 7.63

0.242

  ≤ 5 years

165 (33)

111 (34)

38 (32)

16 (28)

 

 6–10 years

146 (29)

101 (31)

27 (23)

18 (31)

 

  > 10 years

189 (38)

112 (35)

53 (45)

24 (41)

 

Current Medication

 Painkillers (NSAIDs/oral pain medication)

80 (16)

39 (12)

27 (23)

14 (24)

0.005

 Steroid

110 (22)

66 (20)

29 (25)

15 (26)

0.481

DMARDs

0.112

 csDMARDs

329 (66)

214 (66)

79 (67)

36 (62)

 

 csDMARDs + biologic agent

113 (23)

65 (20)

30 (25)

18 (31)

 

 Biologic agent

58 (12)

45 (14)

9 (8)

4 (7)

 

Functional impairment

     

 J-HAQ score (mean ± SD)

0.40 ± 0.81

0.26 ± 0.55

0.52 ± 0.78

0.98 ± 1.50

<0.001

Comorbidity with depression

 Depression

25 (5)

7 (2)

6 (5)

12 (21)

<0.001

Comorbidity other than depression

 Hypertension

79 (16)

52 (16)

16 (14)

11 (19)

0.638

 High cholesterol

42 (8)

24 (7)

11 (9)

7 (12)

0.458

 Diabetes

26 (5)

15 (5)

10 (9)

1 (2)

0.122

 Migraines

11 (2)

0 (0)

5 (4)

6 (10)

<0.001

 Heart condition

8 (2)

3 (1)

2 (2)

3 (5)

0.060

 Anxiety

8 (2)

3 (1)

2 (2)

3 (5)

0.060

  1. N number, % percentage, SD standard deviation, M Million, NSAID nonsteroidal anti-inflammatory drugs, RA rheumatoid arthritis, DMARDs disease modifying anti-rheumatic drugs, csDMARDs conventional synthetic disease modifying anti-rheumatic drugs, J-HAQ Japanese version of the Stanford Health Assessment Questionnaire